TrialJournal of the American Society of Nephrology : JASN2015

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.

Duvuru Geetha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.